Navigation Links
Targeted agent selumetinib shows promise in biliary cancer
Date:4/25/2011

COLUMBUS, Ohio The experimental agent selumetinib has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at The Ohio State University.

Selumetinib, also known as AZD6244 (ARRY-142886), blocks a protein called MEK, which cancer cells need to proliferate and survive.

Biliary cancer is a malignancy of cells lining the bile ducts and gall bladder. About 100,000 patients are diagnosed annually worldwide with the disease, representing 15-20 percent of all liver-cancer cases. Most patients present at later stages of the disease, which has a universally poor outcome.

The findings of this 28-patient, multi-institutional phase II study are reported online in the Journal of Clinical Oncology.

"This malignancy has no good standard of care," says principal investigator Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology and a medical oncologist at Ohio State's Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.

"Our study provides a strong rationale for developing this agent further in larger trials, probably in combination with other drugs, which we hope will enable us to establish a new standard of care for biliary cancers in the near future," adds Bekaii-Saab.

In addition to Ohio State, trial participants included the University of North Carolina, Vanderbilt University and Emory University.

Selumetinib belongs to a class of drugs called protein-kinase inhibitors. The agent selectively inhibits the protein kinases MEK1 and MEK2. It is part of a signaling pathway that is often damaged in biliary cancer cells. The trial showed the following:

  • One patient responded completely the tumor shrunk until it was undetectable and two patients showed partial tumor shrinkage;
  • In 17 patients, the tumor stopped growing. This condition of stable disease lasted up to 16 weeks in the majority of case
    '/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Primary care targeted for suicide prevention efforts
2. Modern targeted drug plus old malaria pill serve a 1-2 punch in advanced cancer patients
3. Scientists devise targeted therapy strategy for rare form of childhood cancer
4. Mass. General study reveals how lung cancers evolve in response to targeted treatment
5. New targeted drug helps smokers stub it out
6. Ohio State study: Targeted ovarian cancer therapy not cost-effective
7. VCU Massey first to combine targeted agents to kill multiple myeloma cells
8. IU Personalized Medicine Institute to develop targeted and individualized treatments
9. Targeted particle fools brains guardian to reach tumors
10. PET scans may allow early prediction of response to targeted therapy of thyroid cancer
11. UMMS and Lundbeck to explore potential targeted therapy for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Georgia (PRWEB) May 29, 2015 National ... celebration for Swedish nationals around the world. The celebration held ... Atlanta and in cooperation with SWEA (Swedish Women’s ... of the year for the Swedish-American community in Georgia. , ... this celebration of Swedish heritage and the long relationship between ...
(Date:5/29/2015)... New England Peptide, Inc. (NEP), in ... Analysis Consortium (CPTAC) and others, today announced the ... of peptide stable isotope standards for biomarker discovery. ... tryptic peptides, offers thousands of fragments spanning over ... accessible to the biomedical research community. Each ...
(Date:5/28/2015)... 2015 Medical Device Cybersecurity Quality ... **FDAnews Webinar**, June 23, 2015 — 1:00 p.m. ... Network connectivity opens up a wealth of possibilities ... minefield of potential liabilities. Devices transmit data on ... manufacturers be sure the information doesn’t fall into ...
(Date:5/28/2015)... May 28, 2015 External Counterpulsation (EECP/ECP) ... all over the United States. There are a growing ... who can experience symptoms of angina and these patients ... stents and/or bypass surgery. , “No option” patients are ... coronary artery disease that is considered unacceptable for heart ...
(Date:5/28/2015)... May 28, 2015 The USC Verdugo Hills ... center management for a decade with a current average healing ... between USC and Wound Care Advantage to provide in-patient wound ... for a drop in the rate of hospital-acquired pressure ... healing is a complex undertaking that can frighten patients and ...
Breaking Medicine News(10 mins):Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 2Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 3Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2
... Wash., April 7, 2008 The Chehalis,Confederated Tribes ... at The Lucky Eagle Casino May 17 and ... appropriately named "The,Return To Honor Veterans Benefit," will ... and Family Fund and the Freedoms Foundation,s,Return to ...
... 2008 DURECT,Corporation (Nasdaq: DRRX ) announced ... to return the rights to CHRONOGESIC(R) licensed from,DURECT ... a product,candidate consisting of a sufentanil containing implantable ... As a result, the,Development, Commercialization and Supply License ...
... Kan., April 7, 2008 With the final,stages ... Wheelchair is now available for purchase. Designed, developed,and ... of Valley,Center, Kansas, the Flight Ultralight features lightweight ... folding,frame wheelchair. The wheelchair weighs just 18 pounds ...
... VNUS(R),Medical Technologies, Inc. (Nasdaq: VNUS ), a ... of peripheral vascular,disease, announced today that it plans to ... 31, 2008, after the close of market on April,21., ... at 2:00 p.m. PT,/ 5:00 p.m. ET on April ...
... to therapeutic applications in humans, researchers say ... neurons derived from reprogrammed adult skin cells successfully ... reduced symptoms of a Parkinson,s disease-like condition in ... the first demonstration that reprogrammed cells can integrate ...
... testimonial by client and ... interview with team physician, WASHINGTON, April 7, 2008 ... nation executive,weight loss consulting service for attorneys by an attorney, announced,today ... its service.,The video will feature a testimonial by a client who ...
Cached Medicine News:Health News:Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 2Health News:DURECT Provides Update on CHRONOGESIC(R) Research Program 2Health News:World's Lightest, Rigid, Folding Frame Wheelchair now in Production 2Health News:VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21 2Health News:Reprogrammed Cells Reduce Parkinson's Symptoms 2Health News:Attorney Weight Loss Video to be Released by Leventhal Weight Loss Incorporated 2
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/324sfl/global_biomedical ) has ... Metal Market 2015-2019" report to their offering. ... grow at a CAGR of 7.27% over the ... for a number of applications in the Medical ... titanium-based alloys, cobalt-based alloys, nitinol, magnesium and related ...
(Date:5/28/2015)... , May 28, 2015  Merck KGaA, ... company for innovative and top-quality high-tech products in ... a global collaboration agreement with the fertility technologies ... advancing fertility science and helping couples create families. ... Germany , a global market leader in ...
(Date:5/28/2015)... Oregon , May 28, 2015 ... "Global Syphilis Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth ... to reach $3.6 billion by 2020. The secondary syphilis ... through 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue ...
Breaking Medicine Technology:Global Biomedical Metal Market 2015-2019 with Biomet, Dentsply, Invibio & Wright Medical Group Dominating 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Reportlinker.com announces that a new market research ... Global Medical Ultrasound Equipment ... This report analyzes the ... US$ Million by the following End-Use Segments: ...
... (Nasdaq: MYL ) today announced the appointment ... Mylan,s fully integrated specialty pharmaceutical business. ... in strategic product launches, marketing, commercialization, sales penetration and ... chief executive officer of MiddleBrook Pharmaceuticals. In this capacity, ...
Cached Medicine Technology:Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25Mylan Names John Thievon President of Dey Pharma 2
... The original Vibratome Semi-Automatic Tissue Sectioning System ... solid tissue sectioning system. Researchers from around ... 1000 Classic for their fresh and fresh ... years. With the Vibratome Automatic ...
... provides a versatile means of sectioning fresh ... The 1500 employs a vibrating blade principle ... The creation of artifacts, the alteration ... and other deleterious effect inherent in freezing ...
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
... this sapphire microtomy knife makes it possible ... Vibratome sections with microscopic resolution similar to ... sections. The sapphire knife allows serial ... thickness in the 6-10 micron range with ...
Medicine Products: